XML 56 R32.htm IDEA: XBRL DOCUMENT v3.22.4
EARNINGS (LOSS) PER SHARE (Tables)
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted The computation of basic and diluted earnings per common share is as follows (in millions, except per share data):
 202220212020
Amounts attributable to Quest Diagnostics’ common stockholders:  
Net income attributable to Quest Diagnostics$946 $1,995 $1,431 
Less: Earnings allocated to participating securities
Earnings available to Quest Diagnostics’ common stockholders – basic and diluted
$942 $1,988 $1,425 
Weighted average common shares outstanding – basic116 125 134 
Effect of dilutive securities:  
Stock options and performance share units
Weighted average common shares outstanding – diluted118 128 136 
Earnings per share attributable to Quest Diagnostics’ common stockholders:  
Basic$8.10 $15.85 $10.62 
Diluted$7.97 $15.55 $10.47 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:
202220212020
Stock options and performance share units— —